FibroGen, Inc. (0IL8.L) LSE

8.40

+0.1319(+1.59%)

Updated at December 04 07:04PM

Currency In USD

Valuation

Market Cap1.32B
Enterprise Value1.35B
P/E Ratio-16.14
PEG Ratio0.01
Price/Sales Ratio-0.46
Price/Book Ratio-0.15
Enterprise/Revenue-1.42
Enterprise/EBITDA-0.8

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.03
Operating Margin1.61

Management Effectiveness

Return On Assets-0.01
Return On Equity0.01

Income Statement

Revenue29.62M
Revenue/Share-18.02
Gross Profit14.06M
EBITDA-142.43M
Net Income-47.58M
Diluted EPS-0.48

Balance Sheet

Total Cash117.98M
Total Cash/Share5.78
Total Debt19.47M
Total Debt/Equity-0.42
Current Ratio1.04
Book Value Per Share-44.79

Price History

52-Week Change-19.29
52-Week High20.8
52-Week Low0.34
Moving Average 50 Days1.58
Moving Average 200 Days2.79

Statistics

Average Volume28,076
Shares Outstanding4.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateJune 17, 2025